
News
Hier finden Sie Neuigkeiten rund um Avextra.
Pressemitteilungen
Aktuelle Pressemitteilungen von Avextra können Sie hier nachlesen.
Avextra AG Announces Closing of EU 17 Million Capital Raise
Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital raise. The CLN will automatically swap into equity at the next capital round currently in…
Avextra erweitert Cannabis-Portfolio um neue Dronabinol-Lösung
Bensheim, 13. Februar 2023 – Apotheken können ab sofort Dronabinol – in Form einer öligen Zubereitung – über Avextra beziehen. Die Dronabinol-Lösung vereinfacht und beschleunigt die Herstellung der Rezepturherstellung. Das…
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
BENSHEIM, Germany, Feb. 08, 2023 (GLOBE NEWSWIRE) — Avextra AG (“Avextra” or the “Company”), a leading vertically-integrated manufacturer of Cannabis-based medicines located in Germany, is pleased to announce the successful…
Medical Device Submission für ein Inhalationsdevice
Avextra has commissioned the Leading Medical Device Specialists Activoris and Actarmo to prepare the EU Medical Device Submission for a Cannabis Extract Inhaler Together these three partners will develop a…
Aus Eurox wird Avextra
Bensheim, 14.9.2022 – Der führende Anbieter von cannabisbasierten Arzneimitteln aus Deutschland mit neuem Namen: Aus Eurox wird Avextra. Avextra stellt sich vom 14. bis zum 17. September 2022 auf dem…
Neues Vorstandsmitglied bei der Eurox AG: Marla Luther ist Chief Strategy Officer
Marla Luther ist neue Chief Strategy Officer bei Eurox Pharma, dem führenden europäischen vertikal-integrierten Hersteller von cannabis-basierten Arzneimitteln, welcher künftig unter dem Namen Avextra firmieren wird. Zum Artikel
Saarbrücker Zeitung: Neues Vorstandsmitglied bei der Eurox AG: Marla Luther
Marla Luther ist neue Chief Strategy Officer bei Eurox Pharma, dem führenden europäischen vertikal-integrierten Hersteller von cannabis-basierten Arzneimitteln, welcher künftig unter dem Namen Avextra firmieren wird. Zum Artikel
Eine Spritze voller Cannabis – FAZ
Die kleine Spritze ist potent. Gerade mal ein Gramm an einer öligen Flüssigkeit enthält sie, doch das reicht, um Patienten bis zu 200 Dosen an Dronabinol zu verabreichen, einem Wirkstoff,…
Avextra AG Announces Closing of EU 17 Million Capital Raise
Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital raise. The CLN will automatically swap into equity at the next capital round currently in…
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
BENSHEIM, Germany, Feb. 08, 2023 (GLOBE NEWSWIRE) — Avextra AG (“Avextra” or the “Company”), a leading vertically-integrated manufacturer of Cannabis-based medicines located in Germany, is pleased to announce the successful…
Medical Device Submission für ein Inhalationsdevice
Avextra has commissioned the Leading Medical Device Specialists Activoris and Actarmo to prepare the EU Medical Device Submission for a Cannabis Extract Inhaler Together these three partners will develop a…
Eurox has rebranded as Avextra
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich…
New board member at Eurox AG: Marla Luther is Chief Strategy Officer
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra name. Full article
A syringe full of cannabis – FAZ
One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business accomplishments. Full article
Good Business with Grass – Metropol April/May 2022
Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further…
Eurox Group raises €4.4M at a significant premium enabling targeted investment – Portuguese Iberis Capital becomes a new institutional investor
As one of the leading European vertically-integrated companies developing and manufacturing cannabis based medicines, Eurox Group, based in Hesse, Germany, has successfully fundraised €4,4 Million from new and existing investors…